Live Pharmaceutical Export data of US Exports to Buenos-aires, our US BL Export data reports include date, quantity, product description, HS code, port, country, and US Pharmaceutical Exporters data. This detailed trade database and trade intelligence report enables businesses to analyze supply patterns, monitor competitor shipments, and explore new opportunities in the US-Buenos-aires Pharmaceutical trade.
Date |
HS Code |
Product Description |
Destination Country |
Unloading Port |
QTY. |
Unit |
Weight |
Exporter Name |
|---|---|---|---|---|---|---|---|---|
|
April 21, 2024 |
30063017 |
OPTIRAY PHARMACEUTICALS OPTIRAY PHARMACEUTICALSNCM 3006.30.17 CONSOLIDATED CARGO |
ARGENTINA | BUENOS AIRES |
7 |
SKIDS |
2407.5 |
Exporter Name |
|
April 15, 2024 |
300242 |
PERISHABLE PRODUCTS. PROTECTANIMAL PHARMACEUTICALS HS CODE30024290 CONSOLIDATED CARGO |
ARGENTINA | BUENOS AIRES |
7 |
PALLET |
2515 |
Exporter Name |
2024-04-21 00:00:00
OPTIRAY PHARMACEUTICALS OPTIRAY PHARMACEUTICALSNCM 3006.30.17 CONSOLIDATED CARGO
7
SKIDS
2407.5
2024-04-15 00:00:00
PERISHABLE PRODUCTS. PROTECTANIMAL PHARMACEUTICALS HS CODE30024290 CONSOLIDATED CARGO
7
PALLET
2515
The database provides shipment-level details such as import date, , quantity, product description, HS code, port information, country of origin, and details of US-based pharmaceutical importers along with data on brand/model/grade specifications.
It enables companies to track import activity at Port buenos-aires, analyze market trends, study product flow, and understand trade dynamics for pharmaceutical products.
Yes. The database includes importer names and details, allowing businesses to identify the most active companies importing pharmaceutical products via Port buenos-aires.
Yes. Since shipment value and quantity are included, businesses can analyze pricing patterns over time for specific pharmaceutical products entering US through this port.
Manufacturers, traders, market analysts, importers, exporters, and supply chain planners rely on this data to gain accurate insights into US’s pharmaceutical import market, optimize trade strategies, and evaluate port-level trade movements.
